As President-elect Trump's transition continues, FDA soon will find out whether his influence will stretch deep inside the agency. High level policy and legal positions that have been filled with career FDA staff could become administration appointees in part to ensure the agency is in line with Trump's and HHS Secretary nominee Tom Price's agendas.
Marc Scheineson, head of the food and drug law practice at Alston and Bird and former FDA associate commissioner for...